SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Maravai LifeSciences Reports Third-Quarter 2026 Results

Third-quarter total revenue rose 10% year over year, while mRNA revenue increased 28%.

MRVI

Related stories